Anti-RUNX3 antibody [EPR20680]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(3 Publications)
Rabbit Recombinant Monoclonal RUNX3 antibody. Suitable for IP, WB, IHC-P and reacts with Human samples. Cited in 3 publications.
View Alternative Names
AML2, CBFA3, PEBP2A3, RUNX3, Runt-related transcription factor 3, Acute myeloid leukemia 2 protein, Core-binding factor subunit alpha-3, Oncogene AML-2, Polyomavirus enhancer-binding protein 2 alpha C subunit, SL3-3 enhancer factor 1 alpha C subunit, SL3/AKV core-binding factor alpha C subunit, CBF-alpha-3, PEA2-alpha C, PEBP2-alpha C
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RUNX3 antibody [EPR20680] (AB224642)
Immunohistochemical analysis of paraffin-embedded human stomach tissue labeling RUNX3 with ab224642 at 1/4000 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use. Nuclear staining on lymphoid cells of human stomach (PMID : 15514019; PMID : 21786422) is observed. Counter stained with hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RUNX3 antibody [EPR20680] (AB224642)
Immunohistochemical analysis of paraffin-embedded human gastric cancer tissue labeling RUNX3 with ab224642 at 1/4000 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use. Nuclear staining on lymphoid cells of human gastric cancer (PMID : 27566570). Counter stained with hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RUNX3 antibody [EPR20680] (AB224642)
Immunohistochemical analysis of paraffin-embedded human diffuse large B cell lymphoma tissue labeling RUNX3 with ab224642 at 1/4000 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use. Nuclear staining on human diffuse large B cell lymphoma (PMID : 27184221). Counter stained with hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IP
Unknown
Immunoprecipitation - Anti-RUNX3 antibody [EPR20680] (AB224642)
RUNX3 was immunoprecipitated from 0.35 mg of Raji (human Burkitt's lymphoma cell line) whole cell lysate with ab224642 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab224642 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.
Lane 1 : Raji whole cell lysate 10 μg (Input).
Lane 2 : ab224642 IP in Raji whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab224642 in Raji whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 10 second.
The molecular weight observed is consistent with what has been described in the literature (PMID : 23700080).
All lanes:
Immunoprecipitation - Anti-RUNX3 antibody [EPR20680] (ab224642)
Predicted band size: 44 kDa
false
- WB
Supplier Data
Western blot - Anti-RUNX3 antibody [EPR20680] (AB224642)
Exposure time : Lane 1 : 3 minutes; Lane 2 : 15 seconds.
Blocking/Dilution buffer : 5% NFDM/TBST.
This target detects both predicted isoforms 44 kDa and 46 kDa, consistent with what has been described in the literature (PMID : 23700080).
All lanes:
Western blot - Anti-RUNX3 antibody [EPR20680] (ab224642) at 1/1000 dilution
Lane 1:
Human thymus tissue lysate at 20 µg
Lane 2:
Human tonsil tissue lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 44 kDa
Observed band size: 44 kDa,46 kDa
true
- WB
Lab
Western blot - Anti-RUNX3 antibody [EPR20680] (AB224642)
Lanes 1 - 4 : Merged signal (red and green). Green - ab224642 observed at 44-46 kDa. Red - loading control, ab130007, observed at 130 kDa.
ab224642 was shown to recognize RUNX3 in wild-type HAP1 cells as signal was lost at the expected MW in RUNX3 knockout cells. Additional cross-reactive bands were observed in the wild-type and knockout cells. Wild-type and RUNX3 knockout samples were subjected to SDS-PAGE. ab224642 and ab130007 (Mouse anti-Vinculin loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-RUNX3 antibody [EPR20680] (ab224642) at 1/1000 dilution
Lane 1:
Wild-type HAP1 whole cell lysate at 20 µg
Lane 2:
RUNX3 knockout HAP1 whole cell lysate at 20 µg
Lane 3:
Ramos whole cell lysate at 20 µg
Lane 4:
HeLa whole cell lysate at 20 µg
Predicted band size: 44 kDa
false
- WB
Supplier Data
Western blot - Anti-RUNX3 antibody [EPR20680] (AB224642)
Blocking/dilution buffer : 5% NFDM/TBST.
Negative control : : MCF-7 (PMID : 21706051).
This target detects both predicted isoforms 44KDa and 46KDa, consistent with what has been described in the literature (PMID : 23700080).
All lanes:
Western blot - Anti-RUNX3 antibody [EPR20680] (ab224642) at 1/1000 dilution
Lane 1:
Raji (human Burkitt's lymphoma cell line) whole cell lysate at 20 µg
Lane 2:
Ramos (human Burkitt's lymphoma cell line) whole cell lysate at 20 µg
Lane 3:
MCF7 (human breast adenocarcinoma cell line) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 44 kDa
Observed band size: 44 kDa,46 kDa
true
Exposure time: 10s
Related conjugates and formulations (1)
-
Anti-RUNX3 antibody [EPR20680] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The function of RUNX3 involves the regulation of cell proliferation differentiation and apoptosis. RUNX3 often forms a complex with the core-binding factor beta (CBFβ) enhancing its stability and DNA-binding capability. This protein is essential in maintaining cellular homeostasis and influencing the immune response particularly through its role in T cell development.
Pathways
RUNX3 is heavily involved in the TGF-beta signaling pathway and the Wnt signaling pathway. It interacts with several proteins such as SMADs in the TGF-beta pathway to modulate gene expression that affects cell growth and survival. Interaction with beta-catenin in the Wnt signaling pathway further emphasizes its importance in regulating cell fate decisions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Annals of surgical oncology 32:10224-10237 PubMed40916017
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of translational medicine 20:120 PubMed35272674
2022
Applications
Unspecified application
Species
Unspecified reactive species
Regenerative therapy 18:430-440 PubMed34754888
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com